Development and Optimization of Epigallocatechin-3-Gallate (EGCG) Nano Phytosome Using Design of Experiment (DoE) and Their In Vivo Anti-Inflammatory Studies
Inflammation is responsible for the development of many diseases that make up a significant cause of death. The purpose of the study was to develop a novel nanophytosomal preparation of epigallocatechin-3-gallate (EGCG) and egg phospholipid complex that has a lower particle size with higher drug loa...
Main Authors: | Mohammad H. Shariare, Kazi Afnan, Faria Iqbal, Mohammad A. Altamimi, Syed Rizwan Ahamad, Mohammed S. Aldughaim, Fars K. Alanazi, Mohsin Kazi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/22/5453 |
Similar Items
-
Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
by: Ying Zhong, et al.
Published: (2012-01-01) -
Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
by: Xin Zhang, et al.
Published: (2016-05-01) -
Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
by: Hiba Siblini, et al.
Published: (2023-01-01) -
Topical Epigallocatechin Gallate (EGCG) 1% for Chronic Plantar Ulcers in Leprosy
by: Riyana Noor Oktaviyanti, et al.
Published: (2020-07-01) -
Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway
by: Yue Cui, et al.
Published: (2021-01-01)